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Abstract: Microorganisms are able to form biofilms within respiratory secretions. Methods to 
disaggregate such biofilms before utilizing standard, rapid, or high throughput diagnostic 
technologies may aid in pathogen detection during ventilator associated pneumonia (VAP) 
diagnosis. Our aim was to determine if sonication of endotracheal aspirates (ETA) would increase 
the sensitivity of qualitative, semi-quantitative, and quantitative bacterial cultures in an animal 
model of pneumonia caused by Pseudomonas aeruginosa or by methicillin resistant Staphylococcus 
aureus (MRSA). Material and methods: P. aeruginosa or MRSA was instilled into the lungs or the 
oropharynx of pigs in order to induce severe VAP. Time point assessments for qualitative and 
quantitative bacterial cultures of ETA and bronchoalveolar lavage (BAL) samples were performed at 
24, 48, and 72 h after bacterial instillation. In addition, at 72 h (autopsy), lung tissue was harvested to 
perform quantitative bacterial cultures. Each ETA sample was microbiologically processed with and 
without applying sonication for 5 min at 40 KHz before bacterial cultures. Sensitivity and specificity 
were determined using BAL as a gold-standard. Correlation with BAL and lung bacterial burden 
was also determined before and after sonication. Assessment of biofilm clusters and planktonic 
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bacteria was performed through both optical microscopy utilizing Gram staining and Confocal Laser 
Scanning Microscopy utilizing the LIVE/DEAD®BacLight kit. Results: 33 pigs were included, 27 and 
6 from P. aeruginosa and MRSA pneumonia models, respectively. Overall, we obtained 85 ETA, 69 
(81.2%) from P. aeruginosa and 16 (18.8%) from MRSA challenged pigs. Qualitative cultures did not 
significantly change after sonication, whereas quantitative ETA cultures did significantly increase 
bacterial counting. Indeed, sonication consistently increased bacterial burden in ETAs at 24, 48, and 
72 h after bacterial challenge. Sonication also improved sensitivity of ETA quantitative cultures and 
maintained specificity at levels previously reported and accepted for VAP diagnosis. Conclusion: 
The use of sonication in ETA respiratory samples needs to be clinically validated since sonication 
could potentially improve pathogen detection before standard, rapid, or high throughput diagnostic 
methods used in routine microbial diagnostics. 
Keywords: biofilm; endotracheal aspirate; sonication; ventilator associated pneumonia; animal 
model; Pseudomonas aeruginosa; Staphylococcus aureus 
 
1. Introduction 
Ventilator associated pneumonia (VAP) may occur after 48 h of oro-tracheal intubation with a 
pooled mean incidence of 10 episodes for 1000 ventilator-days, becoming one of the principal 
Intensive Care Unit (ICU)-acquired infections worldwide [1–3]. Accurate and rapid diagnostic 
methods are key to initiate appropriate antimicrobial treatment and to reduce VAP relapse, 
healthcare costs, mortality, and an indirect effect on the emergence of bacterial resistance [4–6].  
A wide new panel of rapid diagnostic technologies offers promising possibilities for the 
optimization of antibiotics usage [7]. However, adequate implementation of these novel 
technologies is an important consideration as they also present limitations. A notable limitation of 
these technologies is that they provide an important amount of raw data that requires qualified 
interpretation before clinical decision making. Furthermore, new unexpected limitations may 
emerge as these new technologies become routinely implemented. 
Current strategies for microbiological diagnosis of VAP include the microbiological culture of 
one of the following respiratory samples: endotracheal aspirate (ETA), bronchoalveolar aspirate 
(BAS), bronchoalveolar lavage (BAL), and protected specimen brush (PSB). The cut-off for bacterial 
growth to differentiate between colonization and infection are 5 or 6 log CFU/mL for ETA and BAS, 
4 log CFU/mL for BAL, and 3 log CFU/mL for PSB [7–9]. BAL is probably the most representative 
respiratory sample for diagnosing VAP. The reason for this is not only the extensive area of alveoli 
explored, but also the quality of the samples obtained. This allows the detection of intracellular 
organisms, rapid molecular techniques, rapid stains, and qualitative or quantitative cultures [10]. 
The use of ETA instead of BAL has been associated with VAP over-diagnosis, without any impact 
on VAP clinical outcomes [9,11–13]. ETA and BAL cultures offer good positive and negative 
predictive values for VAP diagnosis when utilized before antibiotics administration or change of 
treatment. Nevertheless, differentiation between colonization and infection remains a limitation of 
both semi-quantitative cultures and rapid diagnostic tools. An integrated approach that balances 
clinical judgment and microbiological results is likely the best approach for VAP diagnosis and 
treatment [14]. 
There is consistent evidence that microorganisms can grow in biofilms within respiratory 
secretions, because mucus stimulates biofilm production [15–17]. Biofilm associated infections (BAI) 
are of great clinical concern because the biofilm’s mode of growth is responsible for culture 
negative results, recalcitrance to antimicrobial treatment, and emergence of antimicrobial  
resistance [18,19]. Therefore, it is challenging to implement diagnostic tools without misleading 
diagnostics of BAI. In a landmark study, Trampuz et al. (2007) demonstrated that sonication of the 
sample significantly increased the sensitivity and specificity of bacterial cultures for diagnosis of 
biofilm-associated prosthetic joint infections [20]. Sonication of fluids containing the sample was 
Microorganisms 2017, 5, 62 3 of 13 
recommended in the latest clinical guidelines for the treatment and management of BAI, especially 
for catheter and prosthetic related infections [21]. However, studies are lacking on the utility of 
sonication of respiratory samples to improve VAP diagnosis. 
Recent investigations have demonstrated the presence of biofilm aggregates in BAL samples 
from children with non-cystic fibrosis bronchiectasis by confocal laser scanning microscopy (CLSM) 
[22]. We previously demonstrated the presence of biofilm aggregates growing directly attached to 
the internal surface of endotracheal tubes (ETT) and/or associated within host respiratory secretions 
in an animal model of either methicillin resistant Staphylococcus aureus (MRSA) or  
Pseudomonas aeruginosa [23,24]. 
We hypothesized that sonication of the ETA would increase bacterial release from biofilm 
aggregates, thus improving the sensitivity and specificity of VAP microbiological diagnosis. In this 
study, we compared bacterial qualitative, semi-quantitative, and quantitative cultures before and 
after ETA sonication in an animal model of pneumonia, to determine sonication’s effect on the 
sensitivity and specificity of bacterial cultures and any improvement between ETA and lung 
bacterial growth correlation after ETA sonication. 
2. Material and Methods 
2.1. Population 
All endotracheal aspirates from several ongoing porcine studies of VAP and severe pneumonia 
caused by either Pseudomonas aeruginosa or MRSA were included. 
P. aeruginosa or MRSA cultures were instilled into the lungs or the oropharynx to induce severe 
or ventilator-associated pneumonia in anesthetized, orotracheally intubated, and mechanically 
ventilated pigs, respectively [25,26]. Both models have been previously validated by our group and 
the primary difference is that the bronchial challenge rapidly develops severe pneumonia whilst the 
oropharynx instillation closely mimics the pathophysiology of VAP [25–27]. Briefly, in the first 
model, 75 mL of 7 log CFU/mL of a log-phase culture (Luria Broth (LB), OD600nm = 0.1–0.2) was 
instilled into the lungs, whereas in the second model, 5 mL of 7 log CFU/mL of a log-phase culture 
was instilled twice into the oropharynx. Animals were kept mechanically ventilated and were 
euthanized seventy-two hours after bacterial challenge. The institutional review board and animal 
ethics committee approved all included studies. The project license number that covered the animal 
experiments was the following: 06/17. 9322 (start date 14/12/16 and the expiration date 28/03/19). 
Animals were managed according to the National Institutes of Health guidelines for the Use and 
Care of Animals. Additional details on animal handling and methods are reported in previous 
publications [26]. 
2.2. Collection of Samples 
Paired ETA and BAL were obtained sequentially at 24, 48, and 72 h after bacterial instillation to 
perform qualitative, semi-quantitative, and quantitative bacterial cultures in each animal. Tracheal 
suctioning was performed using a 12-Fr standard CSS (KIMVENT* Closed Suction Systems, 
Kimberly Clark, Irving, TX, USA), as clinically recommended [28]. BAL was performed using a 
bronchoscope (Pentax SAFE-3000; Ricoh Imaging Deutschland GmbH, Hamburg, Germany) in the 
right medium lobe with two 10-mL aliquots of sterile saline solution. The first aliquot was 
discarded, while the second one was used for quantitative microbiology studies. Pigs were 
euthanized after 72 h of bacterial challenge and lung tissue samples were harvested to assess 
quantitative cultures. 
2.3. Microbiological Analysis 
ETA and BAL were liquified in sterile 0.9% saline solution (NaCl), homogenized with a vortex 
mixer and then serially diluted by aseptic transfer of 0.1 mL samples into 0.9 mL of sterile 0.9% 
NaCl solution to yield dilutions of 10−1 to 10−3-fold on blood and MacConkey agar and incubated at 
37 °C over-night. 
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Two-hundred µL of each ETA sample were needed to perform standard cultures, whilst the 
remaining volume of sample (minimum 200 µL) was sonicated in ultrasonic cleaning equipment 
(Branson 3510 E-MT; Bransonic, Danbury, CT, USA) for 5 min at 40 KHz to disaggregate biofilms, 
before undergoing serial dilutions and plating as aforementioned. Bacterial growth was quantified 
and reported as log10 colony-forming units per milliliter (log CFU/mL). Microorganisms were 
identified by mass spectrometry through a Microflex LT (Bruker Daltonik GmbH, Bremen, Germany) 
benchtop instrument controlled by the FLEXCONTROL software (version 3.0; Bruker Daltonics). 
Spectra were analysed with the MALDI BioTyper software (version 3.1; Bruker Daltonics) using the 
pre-processing and Bio- Typer main spectrum (MSP) identification standard methods (mass range 
2000–20,000 m/z) against the default Bruker database. Accuracy of the identification was determined 
by a loga-rithmic score value resulting from the alignment of peaks to the best matching reference 
spectrum. All bacterial quantitative cultures were performed in duplicates. 
Five tissue samples (80–120 mg each) from the five lobes of the lungs were excised and placed 
on sterile vials. Lung biopsies were aseptically homogenized by using a glass tissue mortar, in a 
volume of 0.9% NaCl solution to yield a 1:5 (w/v) suspension of ground tissue. 
2.4. Microscopy Images Acquisition 
To qualitatively assess biofilm clusters and planktonic bacteria, standard Gram staining and 
confocal laser scanning microscopy (CLSM) were performed for both non-sonicated and sonicated 
ETA samples. For Gram staining, the conventional timing and dies were used. Gram-stained slides 
were inspected using a 100× oil objective on a DMRB microscope with equipped with a color camera. 
ETA samples were immediately stained after extraction with the LIVE/DEAD®BacLight kit™ 
(BacLight kit™, Invitrogen, Barcelona, Spain), adding 1.5 µL SYTO9 and 1.5 µL popidium iodide 
(PI) dyes in 1 mL PBS 1× during 15 min in the dark. Then, a very thin layer was smeared onto the 
slide. Images were obtained with a Leica TCS SP5 laser scanning confocal system (Leica 
Microsystems Heidelberg GmbH, Manheim, Germany) equipped with a DMI6000 inverted 
microscope, and a 63× PL APO numerical aperture 0.7 oil immersion objective was used. SYTO® 9 
(Invitrogen, Barcelona, Spain) and PI images were acquired sequentially using 488, 561 nm laser 
lines, AOBS as beam splitter, and emission detection ranges 500–550, 570–620 nm, respectively. The 
confocal pinhole was set at 1 Airy unit and pixel size was 160 nm. 
2.5. Statistical Analysis 
Categorical variables are reported in percentage (%) and continuous variables as mean ± SD if 
normally distributed. Paired samples were compared using the paired t-test. Spearman correlation 
coefficient analyses were performed to determine associations between quantitative variables. For 
the correlation between ETA and lung tissue burden, we selected samples from animals that did not 
receive nebulized antibiotics, because of the extreme high antimicrobial activity in the ETA samples. 
The sensitivity, specificity, and positive and negative predictive value of microbiologic cut-offs 
were calculated with two-by-two contingency tables using standard formulae, when paired ETA 
and BAL samples were available. All statistical analyses were performed using IBM SPSS Statistics 
version 22.0 (Armonk, NY, USA). Two-tailed testing was used and p < 0.05 was considered 
statistically significant. 
3. Results 
3.1. Population 
We analyzed thirty-three pigs, 27 and 6 belonged to P. aeruginosa and MRSA pneumonia 
models, respectively. Twenty-four pigs were intrabronchially challenged with either P. aeruginosa or 
MRSA and included in studies to test pneumonia treatments. In contrast, nine pigs were challenged 
with the bacterial suspension instilled into the oropharynx for VAP preventive studies (Table 1). 
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3.2. Samples Collected 
Overall we obtained 55 BAL and 85 ETA, 69 (81%) from P. aeruginosa versus 16 (19%) from 
MRSA challenged pigs, 61 (72%) belonged to pigs intrabronchially challenged versus 24 (28%) 
obtained from the oropharynx instilled model. Among the 85 ETA samples: 33, 25, and 27 were 
obtained at 24, 48, or 72 h (autopsy) after bacterial challenge, respectively. A total of 36 versus 49 
ETA samples were obtained from untreated versus treated pigs, respectively (Table 1). 
Table 1. Number of animals, microorganism, instillation model, and treatment of the different studies. 
Study Pigs (n) 
Inoculated 
Microorganism 
Bacterial 
Instillation 
ETA (n) BAL (n) Treatment 
Study 1 15 P. aeruginosa Lungs 39 23 
Untreated controls vs. Nebulized 
aminoglycoside vs. IV carbapenem 
Study 2 4 MRSA Oropharynx 10 0 Untreated controls vs. Monoclonal antibody 
Study 3 7 P. aeruginosa Lungs 16 14 Untreated controls vs. IV cephalosporin 
Study 4 5 P. aeruginosa Oropharynx 14 12 Untreated controls vs. Monoclonal antibody 
Study 5 2 MRSA Lungs 6 6 Untreated controls vs. IV lipoglycopeptide 
IV: Intravenous; Dosages: aminoglycoside (300 mg/kg every 6 h), carbapenem (25 mg/kg every 8 h), 
cephalosporin (50 mg/kg every 8 h), Monoclonal antibody against P. aeruginosa (15 mg/Kg single 
dose), lipoglycopeptide (25 mg/kg every 24 h). Study 2 only comprised untreated pigs. 
3.3. Standard Versus Sonicated Cultures 
No differences were found on the qualitative or semi-quantitative VAP microbial diagnosis 
when comparing sonicated versus non-sonicated ETA samples, independent of whether the cut-off 
used was 5 or 6 log CFU/mL. In contrast, in 81 ETA quantitative bacterial cultures (4 were 
uncountable) we found that bacterial burden (log CFU/mL) was significantly higher in sonicated 
versus non-sonicated ETA cultures (4.42 ± 2.58 vs. 4.18 ± 2.5 respectively; p < 0.001) (Figure 1). 
 
Figure 1. Bland–Altman plot showing the differences between sonicated and non-sonicated 
endotracheal aspirate (ETA) paired samples (Mean ± SD). Eighty-one quantitative ETA cultures 
were performed twice: before and after sonication. Each single dot represents the difference 
between bacterial burden of sonicated minus non-sonicated ETA, using non-sonicated values in the 
X axis. Of notice, 52 out of 81 (64%) dots were allocated above zero, 21 out of 81 (26%) at zero, and 8 
out of 81 (10%) below zero. Mean difference ± SD was 0.2 ± 0.3 log CFU/mL (p < 0.001). 
In particular, we analyzed 69 vs. 16 ETA samples obtained from P. aeruginosa vs. MRSA 
models, respectively. Sonicated ETA samples presented higher P. aeruginosa burden versus 
non-sonicated ones. However, the increase in MRSA burden after sonication did not reach 
statistical significance (Table 2). 
Along time assessments, sonicated vs. non-sonicated ETA consistently presented higher 
bacterial burden at 24, 48, and at 72 h after bacterial challenge (Table 2). 
Microorganisms 2017, 5, 62 6 of 13 
Sonication also increased ETA bacterial burden when the bacterial challenge was 
intrabronchial. In contrast, no difference in bacterial burden was found between sonicated and 
non-sonicated quantitative cultures for the 9 pigs that received bacterial instillation of the 
oropharynx (Table 2). 
Table 2. Comparison of non-sonicated versus sonicated ETA bacterial load by microorganism, 
instillation model and time of assessment. 
  
Non-Sonicated ETA 
(log CFU/mL) 
Sonicated ETA  
(log CFU/mL) 
p-Value 
Inoculated microorganism P. aeruginosa (n = 69) 4.03 ± 2.58 4.25 ± 2.79 p < 0.001 
MRSA (n = 16) 4.82 ± 2.04 5.17 ± 1.52 0.159 
Bacterial instillation Lungs (n = 61) 4.10 ± 2.50 4.35 ± 2.65 p < 0.001 
Oropharynx (n = 24) 4.37 ± 2.53 4.61 ± 2.42 0.156 
Time of assessment 
(hours after bacterial challenge) 
24 h (n = 33) 5.24 ± 1.65 5.45 ± 1.71 p < 0.001 
48 h (n = 25) 3.67 ± 2.69 3.79 ± 2.82 0.019 
72 h (n = 27) 3.30 ± 2.84 3.62 ± 2.89 0.052 
3.4. Sensitivity and Specificity 
The sensitivity (Se) and the specificity (Sp) of sonicated and non-sonicated quantitative 
cultures of ETAs used for the diagnosis of pneumonia were determined using BAL  4 log CFU/mL 
as a gold standard. The Se/Sp analysis were performed for both ETA cut-off points: 5 log CFU/mL 
and 6log CFU/mL. No improvement in Se/Sp was detected after ETA sonication when the ETA 
cut-off was 5 log CFU/mL. In contrast, Se improved from 75%, in non-sonicated samples, to 87.5% 
after sonication. Additionally, Sp decreased from 83 to 70.2% when the ETA cut-off was 6 log 
CFU/mL (Table 3). 
Table 3. Effect of ETA sonication on the diagnosis of pneumonia using BAL  4 log CFU/mL as gold standard. 
 
ETA cut-off Se Sp PPV NPV PLR  NLR 
 (95%CI) (95%CI) (95%CI) (95%CI) (95%CI) (95%CI)
Non-sonicated ETA 
5 log CFU/mL 100  46.8 24.2 100 1.88 Undefined 
 (100–100) (32.5–61.1) (9.6–38.9) (100–100) (1.44–2.46)  
6 log CFU/mL 75.0  83.0 42.9 95.1 4.41 0.30 
 (65.6–100) (72.2–93.7) (16.9–68.8) (88.5–100) (2.09–9.3) (0.09–1.01) 
Sonicated  
ETA 
5 log CFU/mL 100  40.4 22.2 100 1.68 Undefined 
 (100–100) (26.4–54.5) (8.6–35.8) (100–100) (1.33–2.12)  
6 log CFU/mL 87.5  70.2 33.3 97.1 2.94 0.18 
 (64.6–100) (57.1–83.3) (13.2–53.5) (91.4–100) (1.76–4.90) (0.03–1.12) 
Se: sensitivity; Sp: Specificity; PPV: positive predictive value; NPV: negative predictive value; PLR: 
positive likelihood ratio; NLR: negative likelihood ratio; CFU: Colony-forming units; ETA: 
endotracheal aspirate. A likelihood ratio is a probability that a subject with a positive (or negative) 
test has the disease in question. If the PLR is over 5 and the NLR is under 0.10, it may be concluded 
that it is essential for a diagnosis and of high validity for use in routine clinical practice. A likelihood 
ratio of 2.0 corresponds to an approximately +15% increase in probability, which is considered a 
slight increase. A likelihood ratio of 5.0 corresponds to an approximately +30% increase in 
probability, which is considered a moderate increase. 
In 55 cases, a moderate correlation was found to exist between non-sonicated and sonicated 
ETA and BAL bacterial loads. However, the non-sonicated vs. sonicated ETA-BAL correlation did 
not significantly improve after sonication (r = 0.51 and r = 0.56, respectively; p = 0.75) (Figure 2). The 
correlation between non-sonicated vs. sonicated ETA and lung tissue bacterial load did not 
significantly improve after sonication either (r = 0.52 and r = 0.57, respectively; p = 0.86), although 
this last analysis included only 15 cases (Figure 3). 
Microorganisms 2017, 5, 62 7 of 13 
 
Figure 2. Correlation between quantitative cultures of ETA and BAL for non-sonicated (A) and 
sonicated samples (B). The histograms represent the number of ETA (on the top) or BAL (right) on 
each bacterial concentration. Moderate correlation was found between non-sonicated and sonicated 
ETA and BAL(r = 0.51 and r = 0.56, respectively; p = 0.75). ETA and BAL cut-off was 6 log CFU/mL 
and 4 log CFU/mL, respectively. After sonication the number of true positives samples increased 
from 6 (11%) to 7 (13%) out of 55 samples. 
 
Figure 3. Correlation between ETA and lung tissue bacterial burden. Of note, in 15 cases a moderate 
correlation was found between non-sonicated or sonicated ETA and lung tissue bacterial burden  
(r = 0.52 and r = 0.57, respectively; p = 0.86). 
3.5. Imaging Biofilms 
P. aeruginosa biofilm aggregates were identified by optical microscopy and CLSM before and 
after sonication (Figure 4). Increased amounts of free-floating bacteria were identified, particularly 
on Gram staining, after ETA sonication at 24, 48, and 72 h after bacterial challenge (Figure 5). 
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Figure 4. Confocal Laser Scanning Microscopy (CLSM) image of ETA samples before and after 
sonication in P. aeruginosa and MRSA infection models. Of note, viable bacteria (in green) stained 
with the SYTO 9, a green Fluorescent Nucleic Acid Stain, were visible. Dead bacteria (in red) stained 
with the propidium iodide (PI) were barely detected. The nucleus and cytoplasm of eukaryotic cells 
from the pig were also stained nonspecifically with the PI and SYTO 9 (large red and green 
blotches). (A) vs. (B) correspond to non-sonicated vs. sonicated ETA (5.14 vs. 6.20 log CFU/mL) after 
72 h of P. aeruginosa instillation with biofilm clusters visible (white arrow). Similarly, (C) vs. (D) 
correspond to non-sonicated vs. sonicated ETA (1.38 vs. 1.88 log CFU/mL) after 72 h of MRSA 
instillation with biofilm clusters and free-floating cocci (white arrows), respectively. (A,B) images 
belong to a pig treated with IV cephalosporin and (C,D) to a pig treated with IV lipoglycopeptide. 
(E) 3D reconstruction of a Gram-negative bacilli biofilm cluster (Imaris, Bitplane, Oxford 
instruments Company, Abingdon, UK). 
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Figure 5. Optical microscopy images of Gram stained ETA before and after sonication. Images (A) 
vs. (B), (C) vs. (D) and (E) vs. (F) correspond to non-sonicated vs. sonicated ETA at 24, 48, and 72 h, 
respectively. Biofilm aggregates (white arrow) were observed before and after sonication. In 
contrast, free-floating bacteria were mainly detected after sonication (black arrow). 
4. Discussion 
Optimizing VAP diagnosis has become a top priority because of the increasing prevalence of 
multidrug resistant pathogens in ICUs and the scarce availability of new therapy options. In this 
context, it is crucial to have a rapid and accurate microbiological diagnosis in order to improve 
treatment guidance. Our study deals with the ability of microorganisms to form biofilms within 
respiratory secretions and highlights sonication as a method to disaggregate them before applying 
either standard, rapid, or high throughput diagnostic technologies in order to improve pathogen 
identification. Smooth sonication is the gold standard for disaggregating biofilms in sputum of cystic 
fibrosis patients [29,30], prosthetic joint devices [20], catheters [31,32], or endotracheal tubes [24,33].  
In line with previous findings, we demonstrated that bacterial counts were higher in sonicated versus 
non-sonicated ETA samples, and this finding was consistent at different time points. 
A BAL threshold 4 log CFU/mL has been used instead of histology as a gold standard [34] for 
the sensitivity and specificity analyses in previous studies [9]. We found 75% Se and 83% Sp of 
non-sonicated ETA, using the cut-off 6 log CFU/mL. Our Se/Sp values are higher than 54%/75% 
reported by Valencia et al. [8], but in line with those reported by Morris et al., or by Jourdain et al. 
using BAL samples [35]. Differences between studies could be influenced by the gold standard used 
or by sample size, which was superior in the Valencia et al study [8]. Interestingly, in our study, 
sensitivity was notably increased after sonication (87.5%) and specificity (70%) was similar [8] or 
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even superior to other previous studies [9]. This increase in sensitivity was only apparent when the 
cut-off of ETA burden was 6 log CFU/mL. This stirs the debate about the most appropriate ETA 
cut-off. Those defending a lower cut-off point opt for greater sensitivity at the expense of losing 
specificity, and vice versa. Our results suggest that with a cut-off 6 log CFU/mL, ETA sonication 
grants higher sensitivity whilst maintaining high specificity. Subsequently, further investigations 
should prospectively investigate the utility of sonication in routine clinical diagnostics. 
Further study is required to determine whether sonication is an effective adjunct for both  
P. aeruginosa and MRSA ETA cultures. Our previous results indicated that both P. aeruginosa and 
MRSA formed biofilms in ETTs and also in respiratory secretions accumulated within the  
ETT [23,24]. Interestingly, Hola V. and coauthors investigated the microbial composition in urinary 
catheters by applying sonication and found that it improved diagnosis of urinary tract infections, 
especially when strong biofilm producers were present [31]. We found that ETA sonication 
increased bacterial counting of P. aeruginosa but did not reach a statistically significant increase for 
MRSA growth. The reason for this could be either attributed to a better biofilm formation capability 
of P. aeruginosa, to a lower number of animals challenged with MRSA, or to a combination of both. 
The latest clinical guidelines for the diagnosis and treatment of BAI strongly recommend the 
use of imaging techniques [21]. Recent investigations have evidenced the presence of biofilms by 
CLSM in BAL samples of children with non-cystic fibrosis bronchiectasis [22]. In the present study 
we confirmed that P. aeruginosa biofilms are also found in ETA samples from a pig model of 
pneumonia. Importantly, biofilms were identified by two independent microscopy techniques 
(Optical microscopy-Gram stain or CLSM-Live/Dead Kit) even after sonication. Our findings are 
relevant as they imply that we may be sub-optimally utilizing existing diagnostic technology if we 
do not disaggregate bacteria from their biofilms before ETA culture. Considering the latest 
advancements in point-of-care diagnosis [36] and that biofilm forming species of the respiratory 
microbiome can trigger pathogen growth [22,37,38], this seems the appropriate time to reconsider 
the diagnosis of biofilms in respiratory samples from intubated ICU patients with suspicion  
of VAP. 
Several limitations should be addressed within our study. First, interestingly, the study 
comprised different pneumonia models that differed by the microorganism, the type of bacterial 
challenge, and the treatment administered. This was especially a limitation for sub-analyses as it 
decreased the sample size in specific cases. Second, BAL missing samples or the exclusion of lung 
tissue samples from pigs treated with nebulized antibiotics limited the Se/Sp and the power of the 
correlation analyses. Ultimately, the beneficial effects of sonication was only detectable in 
quantitative cultures, which are not the routine technique used for microbial diagnosis [39]. 
Nevertheless, our results provide enough evidence that P. aeruginosa biofilms are present in ETA 
samples, even after sonication, and this can influence the sensitivity of not only conventional, but 
also high throughput and rapid diagnostics. 
5. Conclusions 
Sonication of ETA improves the detection of P. aeruginosa within biofilms, improving 
sensitivity and maintaining specificity for VAP microbiological diagnosis in a pig model of 
pneumonia. Its utility in routine clinical laboratory or before rapid or high throughput technologies 
needs to be prospectively investigated. 
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